| Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles S Grabosch, M Bulatovic, F Zeng, T Ma, L Zhang, M Ross, J Brozick, ... Oncogene 38 (13), 2380-2393, 2019 | 210 | 2019 |
| CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer H Zhang, CL Christensen, R Dries, MG Oser, J Deng, B Diskin, F Li, Y Pan, ... Cancer cell 37 (1), 37-54. e9, 2020 | 167 | 2020 |
| Organotin (IV)‐loaded mesoporous silica as a biocompatible strategy in cancer treatment MZ Bulatović, D Maksimović‐Ivanić, C Bensing, S Gómez‐Ruiz, ... Angewandte Chemie International Edition 53 (23), 5982-5987, 2014 | 101 | 2014 |
| ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer J Deng, A Thennavan, I Dolgalev, T Chen, J Li, A Marzio, JT Poirier, ... Nature cancer 2 (5), 503-514, 2021 | 76 | 2021 |
| Platinum(ii/iv) complexes containing ethylenediamine-N,N′-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon … GN Kaluđerović, SA Mijatović, BB Zmejkovski, MZ Bulatović, ... Metallomics 4 (9), 979-987, 2012 | 44 | 2012 |
| Novel methylene modified cyclohexyl ethylenediamine-N, N′-diacetate ligands and their platinum (IV) complexes. Influence on biological activity LE Mihajlović, A Savić, J Poljarević, I Vučković, M Mojić, M Bulatović, ... Journal of inorganic biochemistry 109, 40-48, 2012 | 42 | 2012 |
| The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K D Maksimovic-Ivanic, M Mojic, M Bulatovic, M Radojkovic, M Kuzmanovic, ... Leukemia Research 39 (10), 1088-1095, 2015 | 26 | 2015 |
| Biological activity of neutral and cationic iridium (III) complexes with κP and κP, κS coordinated Ph2PCH2S (O) xPh (x= 0–2) ligands G Ludwig, S Mijatović, I Ranđelović, M Bulatović, D Miljković, ... European Journal of Medicinal Chemistry 69, 216-222, 2013 | 26 | 2013 |
| Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones V Ajdžanović, M Mojić, D Maksimović-Ivanić, M Bulatović, S Mijatović, ... The Journal of membrane biology 246, 307-314, 2013 | 25 | 2013 |
| The interaction between SBA-15 derivative loaded with Ph3Sn(CH2)6OH and human melanoma A375 cell line: uptake and stem phenotype loss D Maksimović-Ivanić, M Bulatović, D Edeler, C Bensing, I Golić, A Korać, ... JBIC Journal of Biological Inorganic Chemistry 24, 223-234, 2019 | 22 | 2019 |
| Synthesis, X-ray structure and strong in vitro cytotoxicity of novel organoruthenium complexes M Mojić, A Savić, VB Arion, M Bulatović, JM Poljarević, D Miljković, ... Journal of Organometallic Chemistry 749, 142-149, 2014 | 15 | 2014 |
| Anticancer Potential of (Pentamethylcyclopentadienyl) chloridoiridium (III) Complexes Bearing κP and κP, κS‐Coordinated Ph2PCH2CH2CH2S (O) xPh (x= 0–2) Ligands G Ludwig, I Ranđelović, D Maksimović‐Ivanić, S Mijatović, MZ Bulatović, ... ChemMedChem 9 (7), 1586-1593, 2014 | 14 | 2014 |
| Study of the anticancer properties of methyl-and phenyl-substituted carbon-and silicon-bridged ansa-titanocene complexes S Mijatović, M Bulatović, M Mojić, S Stošić-Grujičić, D Miljković, ... Journal of Organometallic Chemistry 751, 361-367, 2014 | 13 | 2014 |
| IN VITRO ASSESSMENT OF Ni-Cr AND Co-Cr DENTAL ALLOYS UPON RECASTING: CELLULAR COMPATIBILITY. A Čairović, I Djordjevic, M Bulatović, M Mojić, M Momčilović, ... Digest Journal of Nanomaterials & Biostructures (DJNB) 8 (2), 2013 | 12 | 2013 |
| IN VITRO ASSESSMENT OF Ni-Cr AND Co-Cr DENTAL ALLOYS UPON RECASTING: CELLULAR COMPATIBILITY. A Čairović, I Djordjevic, M Bulatović, M Mojić, M Momčilović, ... Digest Journal of Nanomaterials & Biostructures (DJNB) 8 (2), 2013 | 12 | 2013 |
| Improved in vitro antitumor potential of (O, O′-Diisobutyl-ethylenediamine-N, N′-di-3-propionate) tetrachloridoplatinum (IV) complex under normoxic and hypoxic conditions M Bulatović, MR Kaluđerović, M Mojić, BB Zmejkovski, E Hey-Hawkins, ... European Journal of Pharmacology 760, 136-144, 2015 | 9 | 2015 |
| Alpha-1-antitrypsin antagonizes cisplatin-induced cytotoxicity in prostate cancer (PC3) and melanoma cancer (A375) cell lines M Ljujic, S Mijatovic, MZ Bulatovic, M Mojic, D Maksimovic-Ivanic, ... Pathology & Oncology Research 23, 335-343, 2017 | 5 | 2017 |
| Effect of chain length on the cytotoxic activity of (alkyl-ω-ol) triphenyltin (IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~ Cl| Ph3Sn (CH2) 8OH C Bensing, M Mojić, M Bulatović, D Edeler, D Pérez-Quintanilla, ... Biomaterials Advances 140, 213054, 2022 | 2 | 2022 |
| (18-Crown-6)potassium(I) Trichlorido[28-acetyl-3-(tris-(hydroxylmethyl)amino-ethane)betulinic ester-κN]platinum(II): Synthesis and In Vitro Antitumor Activity GN Kaluđerović, M Bulatović, T Krajnović, R Paschke, B B. Zmejkovski, ... Inorganics 5 (3), 56, 2017 | 2 | 2017 |
| ALPHA-1 antitrypsin affects U0126-induced cytotoxicity in colon cancer cell line (HCT116) M Ljujic, S Mijatovic, MZ Bulatovic, M Mojic, D Maksimovic-Ivanic, ... Molecular Biology 50, 153-156, 2016 | 2 | 2016 |
